Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  WT1 126-134 peptide vaccine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 85
Trial IDs: 11-0545, NCI-2011-03588, NCT01842139
Start Over